RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma.

Mendez-Pena, Javier E

RNA chromogenic in situ hybridization assay with clinical automated platform is a sensitive method in detecting high-risk human papillomavirus in squamous cell carcinoma. [electronic resource] - Human pathology 05 2017 - 184-189 p. digital

Publication Type: Comparative Study; Journal Article

1532-8392

10.1016/j.humpath.2017.02.021 doi


Adult
Aged
Aged, 80 and over
Automation, Laboratory
Biomarkers, Tumor--analysis
Biopsy
Carcinoma, Squamous Cell--chemistry
DNA Probes, HPV
Female
Fixatives
Formaldehyde
Head and Neck Neoplasms--chemistry
Human Papillomavirus DNA Tests
Humans
Immunohistochemistry
In Situ Hybridization--standards
Male
Middle Aged
Molecular Diagnostic Techniques--standards
Papillomaviridae--genetics
Papillomavirus Infections--pathology
Paraffin Embedding
Polymerase Chain Reaction
Predictive Value of Tests
RNA Probes
RNA, Viral--genetics
Reproducibility of Results
Squamous Cell Carcinoma of Head and Neck
Tissue Fixation--methods
Young Adult